Satellos Bioscience Stock Pattern Recognition Long Line Candle

MSCL Stock   11.55  -1.95  -14.44%   
Use the pattern recognition workspace to apply Long Line Candle recognition and other studies to Satellos Bioscience. The analysis highlights pattern recognition signals tied to momentum and continuation and frames technical signals with volatility and risk context.

Recognition
The output start index for this execution was ten with a total number of output elements of fifty-one. The function generated a total of ten valid pattern recognition events for the selected time horizon. The Long Line Candle pattern shows indecision reversal trend for Satellos Bioscience.

Satellos Bioscience Technical Analysis Modules

Most technical analysis of Satellos Bioscience help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Satellos from various momentum indicators to cycle indicators. When you analyze Satellos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

The stock recently underwent a stock split. Satellos Bioscience has reported 12 for 1 split on 30th of January 2026.Satellos Bioscience is accessible through the Toronto Exchange marketplace. This stock section frames Satellos Bioscience within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/B of 6.03. Satellos Bioscience has a market cap of 278.46 M, ROE of -87.59%.

Methodology

Unless otherwise specified, financial data for Satellos Bioscience is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Satellos (CA:MSCL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs rely on public filings and market reference sources and institutional disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Publication cadence can introduce timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Satellos Bioscience may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Be your own money manager

Tracking Satellos Bioscience inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing risk tolerance and investment horizon, Macroaxis optimization evaluates acceptable risk for target return profiles. The process summarizes how much risk can be taken for a given return goal.

More Resources for Satellos Stock Analysis

Other Information on Investing in Satellos Stock

Financial ratios for Satellos Bioscience provide valuation context across profits, cash flow, and enterprise value. They help compare Satellos across valuation measures in a consistent way.